U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07704944) titled 'Safety and Dose-Response of Bletilla Formosana in Prediabetic Subjects' on June 23.
Brief Summary: This study evaluates the safety and preliminary efficacy of Bletilla formosana (BF), a traditional herbal medicine, in adults with prediabetes. Prediabetes is a high-risk condition where blood sugar levels are elevated, often leading to type 2 diabetes. While lifestyle changes are the standard treatment, researchers are exploring herbal supplements as a complementary way to support metabolic health. Preclinical research has shown that BF possesses anti-inflammatory properties and may help regulate blood glucose. Participants in this st...